CLICLINYSE
Loading
EBITDA Over TimeStable
Percentile Rank21
3Y CAGR-19.1%
5Y CAGR-4.5%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-19.1%/yr
vs +33.3%/yr prior
5Y CAGR
-4.5%/yr
Recent deceleration
Acceleration
-52.3pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
2025$249.90M+78.4%
2024$140.05M+67.1%
2020$83.81M-82.2%
2019$471.27M+39.4%
2018$338.15M+7.3%
2017$315.25M-20.9%
2016$398.66M+166.8%
2015$149.41M-52.6%
2014$315.29M+5.0%
2013$300.31M-